Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study - Top-Institutions - MDSpire

Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study

  • By

  • Dina Averbuch

  • Rafael de la Camara

  • Gloria Tridello

  • Nina Simone Knelange

  • Tatiana A. Bykova

  • Marianne Ifversen

  • Veronika Dobsinska

  • Mouhab Ayas

  • Amir Ali Hamidieh

  • Herbert Pichler

  • Antonio Perez-Martinez

  • Simone Cesaro

  • Mikael Sundin

  • Isabel Badell

  • Peter Bader

  • Jan-Erik Johansson

  • Oana Mirci-Danicar

  • Petr Sedlacek

  • Catherine Paillard

  • Brenda Gibson

  • Sarah Lawson

  • Nicolaus Kroeger

  • Selim Corbacioglu

  • Malgorzata Mikulska

  • Jose Luis Piñana

  • Jan Styczynski

  • Per Ljungman

  • February 27, 2023

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    European Society for Blood and Marrow Transplantation (EBMT)
    European Society for Blood and Marrow Transplantation (EBMT)

    Paris, Île-de-France

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Pediatric Hematology
    • Infectious Diseases

  • #2

    Spanish Group of Hematopoietic Stem Cell Transplantation (GETH)
    Spanish Group of Hematopoietic Stem Cell Transplantation (GETH)

    Madrid, Community of Madrid

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Pediatric Hematology
    • Infectious Diseases

  • #3

    St. Jude Children’s Research Hospital
    St. Jude Children’s Research Hospital

    Memphis, Tennessee

    Key Differentiators

    • Pediatric Hematology/Oncology
    • Hematopoietic Cell Transplantation
    • Infectious Diseases

  • #4

    Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

    Boston, Massachusetts

    Key Differentiators

    • Pediatric Hematology/Oncology
    • Hematopoietic Cell Transplantation
    • Infectious Diseases

  • #5

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, Washington

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Pediatric Hematology/Oncology
    • Infectious Diseases

Original Source(s)

Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study

  • by Dina Averbuch, Rafael de la Camara, Gloria Tridello, Nina Simone Knelange, Tatiana A. Bykova, Marianne Ifversen, Veronika Dobsinska, Mouhab Ayas, Amir Ali Hamidieh, Herbert Pichler, Antonio Perez-Martinez, Simone Cesaro, Mikael Sundin, Isabel Badell, Peter Bader, Jan-Erik Johansson, Oana Mirci-Danicar, Petr Sedlacek, Catherine Paillard, Brenda Gibson, Sarah Lawson, Nicolaus Kroeger, Selim Corbacioglu, Malgorzata Mikulska, Jose Luis Piñana, Jan Styczynski, Per Ljungman

  • February 27, 2023

Related Content

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy